Patrick Pagella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Patrick Pagella has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
C Gogal
Lehigh Valley Hospital, Allentown, PA; Lehigh Valley Hospital Network, Allentown, PA
2 shared publicationsD Boorse
Lehigh Valley Hospital, Allentown, PA; Lehigh Valley Hospital Network, Allentown, PA
2 shared publicationsS A Blome-Eberwein
Lehigh Valley Hospital, Allentown, PA; Lehigh Valley Hospital Network, Allentown, PA
2 shared publicationsBrian S. Joho
From the Lehigh Valley Health Network, Regional Burn Center, Allentown, Pennsylvania
1 shared publicationC. Gogal
Regional Burn Center, Lehigh Valley Health Network, Allentown, PA, USA
1 shared publicationChristina Gogal
1 shared publication
Latest Publications
- 8 March 2019
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 40 (Supplement) , S45-S46
66 Laser Treatments for Burn Scars - 6 year Experience
After showing efficacy of fractional photothermolysis in improving physiologic function in burn scars in 2012, we have treated adult and pediatric patients with burn scars on a regular basis. Safety and morbidity of these treatments in large patient series have not sufficiently been documented. 1876 fractional ablative and non-ablative laser treatments were studied in form of a retrospective chart review. Complications of the treatment itself and of the anesthesia associated with treatments, as well as the frequency of treatments, the energy applied per cm2, the size of the scars treated in each session and the Vancouver and POSAS scales were documented. 414 patients, 238 male and 176 female, 308 adults, 106 children, were included. See table 1 for demographics. All patients had received the standard scar treatments prior to laser. A total of 1876, 1116 ablative fractional and 652 non-ablative fractional laser treatments were performed and 108 other (IPL, Q-switched).The average size of scar treated was 565 cm2 in each session. The average energy applied per cm2 was 6.5 Joule. The median time between wound healing and first laser treatment was 150 days. 4 treatments were performed on each patient on average (8 weeks apart). Deep sedation/anesthesia was used in 1207 treatments, local anesthesia was used in 535 treatments and no anesthesia was used in 134 treatments (mostly IPL). There were 26 (2.1%) anesthesia complications, nausea and prolonged recovery. No serious anesthesia complication was reported. 26 (1.38%) post treatment complications were reported, 12 blister formations, 1 open area (non-ablative laser), 13 prolonged itching, none of which required further intervention. The average initial Vancouver scar scale (VSS) was 10.16, POSAS was 36.66. The available final VSS improvement was 1.4points, POSAS was 15.5 points Fractional laser treatments for hypertrophic and symptomatic burn scars are safe and effective in the adult and pediatric population, independent of skin type.The most common complication was nausea post anesthesia. There were no post-laser infections or skin rashes noted in our study population. Applicability of Research to Practice: Immediate Patient demographics Patient demographics
- 8 March 2019
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 40 (Supplement) , S45-S46
66 Laser Treatments for Burn Scars - 6 year Experience
After showing efficacy of fractional photothermolysis in improving physiologic function in burn scars in 2012, we have treated adult and pediatric patients with burn scars on a regular basis. Safety and morbidity of these treatments in large patient series have not sufficiently been documented. 1876 fractional ablative and non-ablative laser treatments were studied in form of a retrospective chart review. Complications of the treatment itself and of the anesthesia associated with treatments, as well as the frequency of treatments, the energy applied per cm2, the size of the scars treated in each session and the Vancouver and POSAS scales were documented. 414 patients, 238 male and 176 female, 308 adults, 106 children, were included. See table 1 for demographics. All patients had received the standard scar treatments prior to laser. A total of 1876, 1116 ablative fractional and 652 non-ablative fractional laser treatments were performed and 108 other (IPL, Q-switched).The average size of scar treated was 565 cm2 in each session. The average energy applied per cm2 was 6.5 Joule. The median time between wound healing and first laser treatment was 150 days. 4 treatments were performed on each patient on average (8 weeks apart). Deep sedation/anesthesia was used in 1207 treatments, local anesthesia was used in 535 treatments and no anesthesia was used in 134 treatments (mostly IPL). There were 26 (2.1%) anesthesia complications, nausea and prolonged recovery. No serious anesthesia complication was reported. 26 (1.38%) post treatment complications were reported, 12 blister formations, 1 open area (non-ablative laser), 13 prolonged itching, none of which required further intervention. The average initial Vancouver scar scale (VSS) was 10.16, POSAS was 36.66. The available final VSS improvement was 1.4points, POSAS was 15.5 points Fractional laser treatments for hypertrophic and symptomatic burn scars are safe and effective in the adult and pediatric population, independent of skin type.The most common complication was nausea post anesthesia. There were no post-laser infections or skin rashes noted in our study population. Applicability of Research to Practice: Immediate Patient demographics Patient demographics
- 9 April 2018
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 39 (suppl_1) , S42-S43
75 Does Topical Steroid after Fractional CO2 Laser Treatment of Scars Make a Clinical Difference?
Fractional ablational laser treatment has become a widely accepted burn scar treatment modality with good evidence for improvement. Many practitioners combine the laser treatment with topical steroid application immediately after treatment, taking advantage of the laser drug delivery pathway elaborated upon by Drs. Waibel and Ozog. This is a prospective, controlled, blinded, IRB approved evaluation of the clinical impact of this technique. Burn survivors (10 to 66 years) with at least two similar hypertrophic scars, undergoing ablational fractional CO2 laser treatments were enrolled. Two scars were randomized to receive laser treatments only or with topical steroid application immediately after. Before and after 5 treatment sessions, objective and subjective scar evaluation was performed (VSS, POSAS, ultrasound, sensation, elasticity, pigment and erythema). Survivor and scar evaluator were blinded to the treatment. 28 Survivors, mean age 39.4, 15 male, 13 female, were enrolled, 22 completed the study. Both scars significantly improved with laser treatments in all measured categories except erythema. The Laser and steroid treated scars improved significantly more in elasticity and pigmentation. Steroid application after ablational fractional scar laser treatment improves some clinical outcomes. The subjective measurement tools are not sensitive enough for scar treatment evaluation. Immediate.
- 9 April 2018
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 39 (suppl_1) , S42-S43
75 Does Topical Steroid after Fractional CO2 Laser Treatment of Scars Make a Clinical Difference?
Fractional ablational laser treatment has become a widely accepted burn scar treatment modality with good evidence for improvement. Many practitioners combine the laser treatment with topical steroid application immediately after treatment, taking advantage of the laser drug delivery pathway elaborated upon by Drs. Waibel and Ozog. This is a prospective, controlled, blinded, IRB approved evaluation of the clinical impact of this technique. Burn survivors (10 to 66 years) with at least two similar hypertrophic scars, undergoing ablational fractional CO2 laser treatments were enrolled. Two scars were randomized to receive laser treatments only or with topical steroid application immediately after. Before and after 5 treatment sessions, objective and subjective scar evaluation was performed (VSS, POSAS, ultrasound, sensation, elasticity, pigment and erythema). Survivor and scar evaluator were blinded to the treatment. 28 Survivors, mean age 39.4, 15 male, 13 female, were enrolled, 22 completed the study. Both scars significantly improved with laser treatments in all measured categories except erythema. The Laser and steroid treated scars improved significantly more in elasticity and pigmentation. Steroid application after ablational fractional scar laser treatment improves some clinical outcomes. The subjective measurement tools are not sensitive enough for scar treatment evaluation. Immediate.
- 1 January 2016
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 37 (6) , 379-387
Prospective Evaluation of Fractional CO2 Laser Treatment of Mature Burn Scars
The authors conducted a prospective study of fractional CO2 laser treatment of mature burn scars, comparing objective and subjective scar measurements evaluating at least one treatment and one control scar on the same patient pre- and post treatments. After institutional review board approval, burn survivors with mature blatant burn scars were invited to enter the study. A series of three fractional CO2 laser treatments was performed in an office setting, using topical anesthetic cream, at 40 to 90 mJ, 100 to 150 spots per cm2. Subjective and objective measurements of scar physiology and appearance were performed before and at least 1 month after the treatment series on both the treated and the control scar. A total of 80 scars, 48 treatment and 32 control scars, were included in the study. Treatment pain score averaged at 4.7/10 during and at 2.4/10 5 minutes after the treatment. All treated scars showed improvement. Objectively measured thickness, sensation, erythema, and pigmentation improved significantly in the treated scars (P = .001, .001, .004, and .001). Elasticity improved, but without statistical significance. Vancouver scar scale assessments by an independent observer improved from 8 to 6; patient self-reported pain and pruritus remained unchanged in both groups. Fractional CO2 laser treatment is a promising entity in the treatment of burn scars. Our study results show significant differences in objective measurements between the treated scars and the untreated control scars over the same time period. In scar treatment studies, the patient/observer and Vancouver scar scales may not be sensitive enough to detect outcome differences.
- 1 January 2016
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 37 (6) , 379-387
Prospective Evaluation of Fractional CO2 Laser Treatment of Mature Burn Scars
The authors conducted a prospective study of fractional CO2 laser treatment of mature burn scars, comparing objective and subjective scar measurements evaluating at least one treatment and one control scar on the same patient pre- and post treatments. After institutional review board approval, burn survivors with mature blatant burn scars were invited to enter the study. A series of three fractional CO2 laser treatments was performed in an office setting, using topical anesthetic cream, at 40 to 90 mJ, 100 to 150 spots per cm2. Subjective and objective measurements of scar physiology and appearance were performed before and at least 1 month after the treatment series on both the treated and the control scar. A total of 80 scars, 48 treatment and 32 control scars, were included in the study. Treatment pain score averaged at 4.7/10 during and at 2.4/10 5 minutes after the treatment. All treated scars showed improvement. Objectively measured thickness, sensation, erythema, and pigmentation improved significantly in the treated scars (P = .001, .001, .004, and .001). Elasticity improved, but without statistical significance. Vancouver scar scale assessments by an independent observer improved from 8 to 6; patient self-reported pain and pruritus remained unchanged in both groups. Fractional CO2 laser treatment is a promising entity in the treatment of burn scars. Our study results show significant differences in objective measurements between the treated scars and the untreated control scars over the same time period. In scar treatment studies, the patient/observer and Vancouver scar scales may not be sensitive enough to detect outcome differences.
- 1 January 2014
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 35 (4) , e205-e216
Burn Disaster-Management Planning
It is vital that preburn center emergency providers have the knowledge and equipment needed to treat burn-injured patients should there be an extended delay in transporting the patients to a burn center as may be the case during a mass-casualty incident or weather-related emergency. Since 2007 a collaborative effort has been underway to build an emergency-response tool kit that provides to and draws from local, state, and federal resources. This tool kit is designed to fill knowledge deficits regarding burn treatment as well as address gaps in stockpiled treatment materials. This tool kit was implemented in four modules: provide equipment, provide guidance, provide education, and provide drill. Module one ensures that equipment needed for treating burn injuries is available to emergency providers. Module two ensures that policies and procedures congruent with the practice of the regional burn center are in place. Module three ensures that preburn center providers are provided education on modern burn care. Module four is to drill. The sum of the effort by the authors is the establishment of a tool kit that enhances the capabilities of preburn center emergency providers. Implementation has led to improved collaborative relationships, increased the awareness of available resources, and reduced knowledge deficit regarding burn care among preburn center providers. This tool kit provides greater continuity of care for all burn patients affected by a delay in transport to a burn center, and its modular structure makes it adaptable to other regions as a whole or in part.
- 1 January 2014
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 35 (4) , e205-e216
Burn Disaster-Management Planning
It is vital that preburn center emergency providers have the knowledge and equipment needed to treat burn-injured patients should there be an extended delay in transporting the patients to a burn center as may be the case during a mass-casualty incident or weather-related emergency. Since 2007 a collaborative effort has been underway to build an emergency-response tool kit that provides to and draws from local, state, and federal resources. This tool kit is designed to fill knowledge deficits regarding burn treatment as well as address gaps in stockpiled treatment materials. This tool kit was implemented in four modules: provide equipment, provide guidance, provide education, and provide drill. Module one ensures that equipment needed for treating burn injuries is available to emergency providers. Module two ensures that policies and procedures congruent with the practice of the regional burn center are in place. Module three ensures that preburn center providers are provided education on modern burn care. Module four is to drill. The sum of the effort by the authors is the establishment of a tool kit that enhances the capabilities of preburn center emergency providers. Implementation has led to improved collaborative relationships, increased the awareness of available resources, and reduced knowledge deficit regarding burn care among preburn center providers. This tool kit provides greater continuity of care for all burn patients affected by a delay in transport to a burn center, and its modular structure makes it adaptable to other regions as a whole or in part.
- 1 May 2007
- Published by Wolters Kluwer Health in Orthopaedic Nursing
- Vol. 26 (3) , 169-174
A Randomized Trial to Evaluate Compliance in Terms of Patient Comfort and Satisfaction of Two Pneumatic Compression Devices
Venous thromboembolism (VTE) incidence can be substantially reduced with prophylaxis, which includes pneumatic compression device (PCD) use. To determine whether patient comfort and satisfaction correlated to compliance in wearing PCDs, patients were randomly assigned to either of two effective calf-high PCDs. Education and handouts were provided to both groups. Patients were given a survey rating their comfort, satisfaction, and compliance. At the conclusion of the study, healthcare providers completed a questionnaire comparing both PCDs. A total of 65 patients participated. The main significant differences between groups were seen in the patient perceptions questionnaire for two items: "the device was hot" (p = .014) and "device made my legs sweat" (p = .029). The PCD that provided more comfort and satisfaction was worn for a greater amount of time, 85% vs. 81%, respectively. Results suggest that patients are more compliant with a PCD that promotes patient comfort when worn.
- 1 May 2007
- Published by Wolters Kluwer Health in Orthopaedic Nursing
- Vol. 26 (3) , 169-174
A Randomized Trial to Evaluate Compliance in Terms of Patient Comfort and Satisfaction of Two Pneumatic Compression Devices
Venous thromboembolism (VTE) incidence can be substantially reduced with prophylaxis, which includes pneumatic compression device (PCD) use. To determine whether patient comfort and satisfaction correlated to compliance in wearing PCDs, patients were randomly assigned to either of two effective calf-high PCDs. Education and handouts were provided to both groups. Patients were given a survey rating their comfort, satisfaction, and compliance. At the conclusion of the study, healthcare providers completed a questionnaire comparing both PCDs. A total of 65 patients participated. The main significant differences between groups were seen in the patient perceptions questionnaire for two items: "the device was hot" (p = .014) and "device made my legs sweat" (p = .029). The PCD that provided more comfort and satisfaction was worn for a greater amount of time, 85% vs. 81%, respectively. Results suggest that patients are more compliant with a PCD that promotes patient comfort when worn.